IRCT20200317046797N3招募中3 期
To evaluate the effectiveness of intravenous immunoglobulin (IVIG) for the treatment of COVID-19-induced cytokine storm
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Respiratory rate more than 30
- •PaO2/FiO2 less than 300 mm Hg
- •Positive PCR for COVID -19
- •Age 18-65 year
排除标准
- •Sensitivity to IVIG
- •IgA deficiency syndrome
研究者
相似试验
已完成
2 期
The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocolCOVID-19 disease.COVID-19, virus identifiedU07.1IRCT20200325046859N1Mashhad University of Medical Sciences50
招募中
3 期
Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trialIRCT20201004048922N1Tehran University of Medical Sciences75
终止
4 期
A Randomised Controlled trial of intravenous immunoglobulin (IVIg) compared with pulse methyl-prednisolone for the treatment of chronic active antibody mediated rejectioACTRN12612000252819Dr William Mulley30
尚未招募
2 期
A study comparing two groups of patients undergoing bilateral total knee replacement one receiving only injection dexamethasone and other receiving injection levosulpiride with injection dexamethasone to assess the effect for post operative nausea and vomiting prophylaxis.CTRI/2023/08/056491Dr Sunny Rupal
已完成
不适用
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemiaJPRN-UMIN000015179agoya University Graduate School of Medicine30